Schedule 13G ownership disclosure

INSYS THERAPEUTICS INC

Security class unavailable · CUSIP: 45824V209

Event date: 2013-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
21,124,805
Percent of class
61.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-14-021027
Form type
SC 13G
Filer
Insys Therapeutics, Inc.
CIK
CIK 1516479
Filed
Nov 18, 2014
Reporting period
Dec 31, 2013
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub